Výsledky vyhľadávania - "IMMUNE-MEDIATED DORMANCY"

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Autori: Qiang Lan Curzio Rüegg David Barras a ďalší

Prispievatelia: Qiang Lan Curzio Rüegg David Barras a ďalší

Zdroj: Oncogene
Oncogene, vol. 38, no. 15, pp. 2814-2829

Predmety: Receptor, ErbB-2, Interferon Regulatory Factor-7, Nude, Local -- metabolism, Mice, SCID, Tumor -- metabolism, Breast Neoplasms -- drug therapy -- metabolism, Chemotherapy, Adjuvant -- methods, PATHWAY, Mice, 0302 clinical medicine, Mice, Inbred NOD, Antineoplastic Combined Chemotherapy Protocols, Receptor, ErbB-2 -- metabolism, TUMOR-INFILTRATING LYMPHOCYTES, Inbred BALB C, Genetics & Heredity, Mice, Inbred BALB C, Tumor, SITE, Neoadjuvant Therapy -- methods, Sciences bio-médicales et agricoles, Biomarkers, Tumor -- metabolism, Neoadjuvant Therapy, 3. Good health, Adjuvant -- methods, Doxorubicin -- pharmacology, Oncology, Chemotherapy, Adjuvant, Interferon Type I, Female, Cancers, Life Sciences & Biomedicine, Antineoplastic Combined Chemotherapy Protocols -- pharmacology, Receptor, EXPRESSION, Biochemistry & Molecular Biology, Receptor, erbB-2, 3101 Biochemistry and cell biology, Interferon-beta -- metabolism, ErbB-2 -- metabolism, Methotrexate -- pharmacology, Mice, Nude, Breast Neoplasms, SCID, Article, Cell Line, MECHANISMS, 03 medical and health sciences, Interferon Regulatory Factor-7 -- metabolism, 3211 Oncology and carcinogenesis, Cell Line, Tumor, Animals, Antineoplastic Combined Chemotherapy Protocols/pharmacology, Biomarkers, Tumor/metabolism, Breast Neoplasms/drug therapy, Breast Neoplasms/metabolism, Chemotherapy, Adjuvant/methods, Doxorubicin/pharmacology, Epirubicin/pharmacology, Humans, Interferon Regulatory Factor-7/metabolism, Interferon Type I/metabolism, Interferon-beta/metabolism, Methotrexate/pharmacology, Neoadjuvant Therapy/methods, Neoplasm Recurrence, Local/metabolism, Receptor, ErbB-2/metabolism, Biomarkers, Tumor, Chemotherapy, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Neoplasm Recurrence, Local -- metabolism, Epirubicin, Science & Technology, IMMUNE-MEDIATED DORMANCY, Médecine pathologie humaine, 1103 Clinical Sciences, Cell Biology, Interferon-beta, Epirubicin -- pharmacology, Interferon Type I -- metabolism, Cancérologie, Neoplasm Recurrence, Methotrexate, Doxorubicin, CELLS, METASTASIS, Inbred NOD, Neoplasm Recurrence, Local, Biomarkers, RESISTANCE

Popis súboru: application/pdf; 1 full-text file(s): application/pdf

Prístupová URL adresa: https://www.nature.com/articles/s41388-018-0624-2.pdf
https://pubmed.ncbi.nlm.nih.gov/30546090
https://www.nature.com/articles/s41388-018-0624-2
https://www.nature.com/articles/s41388-018-0624-2.pdf
https://serval.unil.ch/notice/serval:BIB_94A8CCA9EF90
https://difusion.ulb.ac.be/vufind/Record/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/283375/Details
https://researchportal.helsinki.fi/en/publications/type-i-interferonirf7-axis-instigates-chemotherapy-induced-immuno
https://doc.rero.ch/record/324696
https://lirias.kuleuven.be/handle/123456789/668229
https://doi.org/10.1038/s41388-018-0624-2
http://hdl.handle.net/10138/312010
https://serval.unil.ch/resource/serval:BIB_94A8CCA9EF90.P001/REF.pdf
https://serval.unil.ch/notice/serval:BIB_94A8CCA9EF90
http://nbn-resolving.org/urn/resolver.pl?urn=urn:nbn:ch:serval-BIB_94A8CCA9EF908
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/283375
http://doc.rero.ch/record/324696/files/rue_tia.pdf

Type I interferon/IRF7 axis instigates chemotherapy-induced immunological dormancy in breast cancer

Autori: Lan, Qiang Peyvandi, Sanam Duffey, Nathalie a ďalší

Prispievatelia: Lan, Qiang Peyvandi, Sanam Duffey, Nathalie a ďalší

Predmety: TUMOR-INFILTRATING LYMPHOCYTES, IMMUNE-MEDIATED DORMANCY, CELLS, METASTASIS, MECHANISMS, EXPRESSION, RESISTANCE, PATHWAY, SITE, Cancers

Popis súboru: application/pdf

Relation: We thank Dr. J. Sleeman (Medical Faculty at Heidelberg University, Mannheim, Germany) for providing D2A1/D2.0R cells, Dr. Fred R. Miller (Michigan Cancer Foundation, Detroit, MI, USA) for providing 4T1 cells, Dr. Khalil Zaman (Department of Oncology), University Hospital, University of Lausanne, Lausanne, Switzerland) for providing chemotherapeutic drugs. This work was supported by grants from Swiss National Science Foundation (31003A_159824), The Swiss Cancer League (KFS-2814-08-2011); the Medic Foundation, the Molecular Oncology Program of the National Center of Competence in Research (NCCR), a research instrument of the Swiss National Science Foundation.; http://hdl.handle.net/10138/312010; 000464121600011

Dostupnosť: http://hdl.handle.net/10138/312010

Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer

Autori: Hao-fan Wang Sha-sha Wang Mei-chang Huang a ďalší

Zdroj: Frontiers in Oncology, Vol 9 (2019)

Predmety: cancer dormancy, immune-mediated dormancy, metastases, disseminated tumor cells (DTCs), immunotherapies, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

Popis súboru: electronic resource

Relation: https://www.frontiersin.org/article/10.3389/fonc.2019.00498/full; https://doaj.org/toc/2234-943X

Prístupová URL adresa: https://doaj.org/article/dc4a660d1a2041d9a050628778bd6481